Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey.

Hak AE, Choi HK. · 2008

Read Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. by Hak AE, Choi HK. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2592803.txt.

Introduction

Hak and Choi examined in 2008 whether menopause and hormone use move uric acid levels in American women. They used NHANES III, the third round of the US national health and nutrition survey. High uric acid causes gout, which is common in older women, yet hormonal influences had never been comprehensively tested. The analysis covered 7,662 women aged 20 and over surveyed between 1988 and 1994.

After adjustment for diet, body size, alcohol, kidney function, blood pressure, and diuretic use, menopause was tied to higher uric acid. Women with natural menopause ran 0.34 milligrams per decilitre above premenopausal women. Surgical menopause ran 0.36 higher. Current hormone users among postmenopausal women ran 0.24 lower than non-users. The crude rise of uric acid with age vanished after adjustment, suggesting menopause and related factors, not age itself, drive it.

Catalog record

CREATORHak AE, Choi HK.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2592803

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Menopause, postmenopausal hormone use and serum uric acid levels in US women – The Third National Health and Nutrition Examination Survey By A Elisabeth Hak, Hyon K Choi Published in: Arthritis Research & Therapy DOI: 10.1186/ar2519 ABSTRACT Abstract Introduction Despite the substantial prevalence of gout in the ageing female population, female hormonal influence has not been comprehensively examined. We evaluated and quantified the potential independent association between menopause, postmenopausal hormone use and serum uric acid levels in a nationally representative sample of women. Methods Using data from 7662 women aged 20 years and older in the Third National Health and Nutrition Examination Survey (1988 to 1994), we examined the relation between menopause, postmenopausal hormone use and serum uric acid levels. We used multivariate linear regression to adjust for other risk factors for hyperuricaemia such as dietary factors, age, adiposity, alcohol use, renal function, hypertension and diuretic use. Results Menopause was associated with higher serum uric acid levels. After adjusting for covariates, serum uric acid levels among women with natural menopause and surgical menopause were greater than premenopausal women by 0.34 mg/dl (95% confidence interval [CI], 0.19 to 0.49) and 0.36 mg/dl (95% CI, 0.14 to 0.57), respectively. Current postmenopausal hormone use was associated with a lower serum uric acid level among postmenopausal women (multivariate difference, 0.24 mg/dl [95% CI, 0.11 to 0.36]). The serum uric acid levels increased with increasing age categories (crude difference between 20 to 29 years and 70 years and over = 1.03 mg/dl, p for trend < 0.001), but this increase was not present after adjusting for other covariates (p for trend = 0.66). Conclusions These findings from a nationally representative sample of US women indicate that menopause is independently associated with higher serum uric acid levels, whereas postmenopausal hormone use is associated with lower uric acid levels among postmenopausal women. The age-associated increase in serum uric acid levels in women may be explained by menopause and other age-related factors. INTRODUCTION Despite the doubling of the incidence of gout among women over the past 20 years [1] and the substantial prevalence particularly in the ageing female population [2], little is known about the risk factors for gout and hyperuricaemia specifically among women. Given the important gender differences in the frequency of gout and serum uric acid levels, the risk factors for gout may vary between genders. A central factor behind these differences is thought to be female hormonal influence, but its magnitude has not been comprehensively examined and quantified. Thus, it is unknown if menopause is associated with serum uric acid levels independent of age and other covariates and if so, by what magnitude. Conversely, postmenopausal hormone use may be independently associated with lower serum uric acid levels, but no nationally representative information is available. Furthermore, previous studies reported an age-dependent increase in serum uric acid levels among women [3-5], but it is unknown if this increase is independent of menopausal effect or other age-related factors. To study these issues, we examined a nationally representative sample of women (the US Third National Health and Nutritional Examination Survey [NHANES III]) [6,7]. MATERIALS AND METHODS Study population Conducted between 1988 and 1994, the NHANES III included a representative sample of the non-institutionalised civilian US population, which was selected by using a multistage, stratified sampling design [6]. After a home interview, participants were invited to attend examination sessions where blood and urine specimens were obtained. For participants unable to attend the examination sessions for health reasons, a blood sample was obtained during the home interview. Our analysis was limited to women aged 20 years or older who attended the medical examination: of these women 7662 had complete information. We repeated our analyses among 7531 participants after excluding those who self-reported gout or were taking allopurinol or uricosuric agents (n = 131). The NHANES III underwent institutional review board approval and written informed consent was obtained from participants. Uric acid measurement Serum uric acid was measured by oxidisation with the specific enzyme uricase to form allantoin and hydrogen peroxide (Hitachi Model 737 Multichannel Analyzer, Boehringer Mannheim Diagnostics, Indianapolis, IN). Details about quality-control procedures have been published elsewhere [7]. Values are reported in milligrams per decilitre; to convert to micromoles per litre, multiply by 59.48. Assessment of menopausal status and postmenopausal hormone use Participants were categorised as premenopausal (ovarian function intact), surgically menopausal (both ovaries removed surgically before cessation of menses) or naturally menopausal (nonsurgical loss of ovarian function) [8]. Participants with no history of reproductive surgery were classified as premenopausal if they reported having had a menstrual period during the previous 12 months and postmenopausal if they did not, consistent with World Health Organization criteria [8]. Women who had undergone a hysterectomy (without ovariectomy) that coincided with the date of the last menstrual period were assigned a menopausal classification on the basis of age (< 51 years were premenopausal; ≥ 51 years were naturally menopausal) [8]. Women with no history of hysterectomy or ovariectomy who were current users of hormone replacement therapy were classified in the same way. Women who had undergone bilateral ovariectomy that coincided with the date of the last menstrual period were classified as surgically menopausal [8]. Women who had undergone hysterectomy or ovariectomy after the date of the last menstrual period were classified as naturally menopausal. The amount of time since menopause was estimated as the difference in years between age at the time of the NHANES interview and self-reported age at the time of the last menstrual period or ovariectomy, whichever came first. Women were classified as current users, past users or never users of postmenopausal hormone use on the basis of self-reported data from the examination questionnaire [8]. Duration of postmenopausal hormone use in years was also ascertained by self-report at the time of the examination. Assessment of covariates The average daily intakes of total meat, seafood, dairy foods, sugar-sweetened soft drinks and coffee were derived from responses to a food frequency questionnaire. The food frequency questionnaire assessment of dietary intake has been shown to be a valid and reliable method of assessing average dietary consumption [9,10]. The NHANES III collected information on body measurements (including height and weight), medication use (including diuretics, anti-hypertensives, allopurinol and uricosuric agents), medical conditions (including self-reported physician-diagnosed diabetes, hypertension and gout) and serum creatinine levels. Glomerular filtration rate (GFR) was estimated by using the simplified Modification of Diet in Renal Disease study equation: GFR (ml/min/1.73 m2) = 186 × (serum creatinine level [mg/dl])-1.154 × (age)-0.203 × [0.742, if female] × [1.212, if black] [11-13]. Body mass index was calculated by dividing the weight in kilograms by the square of the height in metres. Statistical analysis All statistical analyses were computed using survey commands of STATA (eg, SVYMEAN and SVYREG (StataCorp LP Texas)) to incorporate sample weights and adjust for clusters and strata of the complex sampling design. We used linear regression modelling to evaluate the relation between menopause, postmenopausal hormone use and serum uric acid levels. These models were adjusted for age; smoking status; body mass index; use of diuretics, beta-blockers, allopurinol and uricosuric agents; self-reported hypertension; GFR; and intake of total energy, total meats, seafood, dairy foods, sugar-sweetened soft drinks and coffee. When categorical analyses suggested linear

Read the complete text